Products |
PrimeWire Prestige Plus
Related Content
March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...
March 04, 2026 
Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...
February 18, 2026 
Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...
January 05, 2026 
Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...
November 12, 2025 
Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...
October 21, 2025 
Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...
August 25, 2025 
Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...
August 21, 2025 
Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...
August 20, 2025 
Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...
August 04, 2025 
July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...
July 22, 2025 